Apoptotic Activity by Chemo-preventive Natural Compounds against Oral Squamous Cell Carcinoma

Main Article Content

Nisha Rani
Neeraj Vaishnav
Runjhun Mathur
Abhimanyu Kumar Jha


The general frequency and mortality consisting of Oral Squamous Cell Carcinoma (OSCC) is very high and the overall number of oral cancers has been consistently increasing in the world. Oral Squamous Cell Carcinoma (OSCC) is the most typical variety of oral cancer; it causes damage to  oral epithelial cells due to accumulation consisting of multiple genetic changes in the cells. OSCC continues to be major cause of mortality in sufferers along with head and neck cancers. Alcohol, smoking and tobacco chewing alone or as well as smokeless tobacco and betel quid are potential carcinogens which contribute to the far natural event of OSCC. The current review focuses on apoptosis induction in human Oral Squamous Cell Carcinoma (OSCC) cells. Several natural products, chemotherapeutic drugs metabolic inhibitors, gene manipulations and hormone receptor ligands cause the general programmed cell death immediately or not directly via relapsing the anti-apoptotic pathways. The main focus of this review is on Apoptotic activities caused by Natural compounds in OSCC which provide us a chemoprevention against cancer.

Receptor, oral cancer, metabolic inhibitors, genetic mutations.

Article Details

How to Cite
Rani, N., Vaishnav, N., Mathur, R., & Jha, A. K. (2020). Apoptotic Activity by Chemo-preventive Natural Compounds against Oral Squamous Cell Carcinoma. Asian Oncology Research Journal, 3(3), 6-15. Retrieved from https://journalaorj.com/index.php/AORJ/article/view/30112
Minireview Article


Bradley A. Schiff, MD, Montefiore Medical Center, The University Hospital of Albert Einstein College of Medicine; 2019.

Elmore S. Apoptosis: A review of of programmed cell death. Toxicology Pathology. 2007;35(4):495-516,.

Loreto Carla, La Rocca Giampiero, Anzalone Rita, Caltabiano Rosario, Vespasiani Giuseppe, Castorina Sergio, J. Ralph David, Cellek Selim, Musumeci Giueseppe, Giunta Salvatore, Djinovic Rados, Basic Dragoslav, Sansalone Salvatore, BioMed Research International, Hindawi Publishing Corporation. 2014;10.

Ram Hari, Sarkar Jayanta, Kumar Hemant, Konwar Rituraj, Mohammad Sadab, Bhatt MLB. J Maxillofac Oral Surg. 2011; 10(2):132-137.

Chu C, Deng J, Man Y and Qu Y: Green tea extracts epigallocatechin-3-gallate for different treatments. Biomed res int 2017: 5615647; 2017.

Imai K, Suga K and nakachi K: cancer-preventive effects of drinking green tea among a Japanese population. Prev Med. 1997; 26: 769-775.

Lecumberri E, Dupertuis YM, Miralbell R, Pichard C. Green tea polyphenol epigallocatechin-3-gallate (eGcG) as adjuvant in cancer therapy. Clin nutr. 2013; 32: 894-903.

Scholzen T, Gerdes J: The Ki-67 protein: From the known and the unknown. J cell Physiol. 2000;182: 311-322.

Hsu, Stephen, Farrey, Kajuana, Wataha, John, Lewis, Jill, Borke, James, Singh, Baldev, Qin, Haiyan, Lapp, Carol, Lapp, David, Schuster, George. Role of p21 WAF1 in green tea polyphenol-induced growth arrest and apoptosis of oral carcinoma cells. Anticancer research. 2005;25:63-7.

Hitoshi Yoshimura, Hisato Yoshida, Shinpei Matsuda, Takashi Ryoke, Keiichi Ohta, Masahiro Ohmori, Satoshi Yamamoto, Tamotsu Kiyoshima, Motohiro Kobayashi and Kazuo Sano; Molecular Medicine Reports. 2019;20:1139-1148.

Cromie MM, Gao W. Epigallocatechin-3-gallate enhances the therapeutic efects of leptomycin B on human lung cancer a549 cells. Oxid Med Cell Longev. 2015;2015: 217304.

Zou C, Liu H, Feugang JM, Hao Z, Chow HH, Garcia F. Green tea compound in chemoprevention of cervical cancer. Int J Gynecol Cancer. 2010;20:617–24.

Li S, Wu L, Feng J, Li J, Liu T, Zhang R, Xu S, Cheng K, Zhou Y, Zhou S, et al. In vitro and in vivo study of epigallocatechin-3-gallate-induced apoptosis in aerobic glycolytic hepatocellular carcinoma cells involving inhibition of phosphofructokinase activity. Sci Rep. 2016;6:28479.

Kim D, Mollah ML, Kim K. Induction of apoptosis of SW480 human colon cancer cells by (−)-epicatechin isolated from Bulnesia sarmienti. Anticancer Res. 2012; 32:5353–61.

Chen C, Shen GX, Hebbar V, Hu R, Owuor ED, Kong ANT. Epigallocatechin3-gallate-induced stress signals in HT-29 human colon adenocarcinoma cells. Carcino-genesis. 2003;24:1369–78.

Yokouchi M, Hiramatsu N, Hayakawa K, Okamura M, Du S, Kasai A, Takano Y, Shitamura A, Shimada T, Yao J, Kitamura M. Involvement of selective reactive oxygen species upstream of proapoptotic branches of unfolded protein response. J Biol Chem. 2008;283:4252–60.

Hastak K, Gupta S, Ahmad N, Agarwal MK, Agarwal ML, Mukhtar H: Role of p53 and NF-kappaB in epigallocatechin-3- gallate-induced apoptosis of LNCaP cells. Oncogene. 2003;22:4851- 4859.

Lin HY, Hou SC, Chen SC, Kao MC, Yu CC, Funayama S, Ho CT and Way TD: (−)-Epigallocatechin gallate induces Fas/ CD95-mediated apoptosis through inhibiting constitutive and IL-6-induced JAK/STAT3 signaling in head and neck squamous cell carcinoma cells. J Agric Food Chem. 2012;60:2480–2489.

Rivera C: Essentials of oral cancer. Int J Clin Exp Pathol. 2015;8:11884–11894.

Bodduluru LN, Kasala ER, Thota N, Barua CC, Sistla R. Chemopreventive and therapeutic effects of nimbolide in cancer: the underlying mechanisms. Toxicol in vitro. 2014;28(5):1026–1035.

Glinsukon T, Somjaree R, Piyachaturawat P, Thebtaranonth Y. Acute toxicity of nimbolide and nimbic acid in mice, rats and hamsters. Toxicol Lett. 1986;30(2):159–166.

Roy MK, Kobori M, Takenaka M, et al. Antiproliferative effect on human cancer cell lines after treatment with nimbolide extracted from an edible part of the neem tree (Azadirachta indica). Phytother Res. 2007;21(3):245–250.

Bundela S, Sharma A, Bisen PS. Potential compounds for oral cancer treatment: resveratrol, nimbolide, lovastatin, bortezomib, vorinostat, berberine, pterostilbene, deguelin, andrographolide, and colchicine. PLoS One. 2015;10: e0141719.

Josephraj Sophia, Jaganathan Kowshik, Anju Dwivedi, Sujit K Bhutia, Bramanandam Manavathi, Rajakishore Mishra, Siddavaram Nagini; Cell Death and Disease. 2018;9:1087.

Su-Yu Chien, Ching-Hui Hsu,Chia-Chieh Lin, Yi-Ching Chuang, Yu-Sheng Lo, Yi-Ting His, Ming-Ju Hsieh, Mu-Kuan Chen, Environmental Toxicology. 2017;1–8.

Elumalai P, Gunadharini DN, Senthilkumar K, Banudevi S, Arunkumar R, Benson CS, Sharmila G, Arunakaran J. 2 Elsevier Ireland Ltd. 2012;215:131–142.

Harish Kumar G, Chandra Mohan KV, Jagannadha Rao A, Nagini S. Nimbolide a limonoid from Azadirachta indica inhibits proliferation and induces apoptosis of human choriocarcinoma (BeWo) cells. Investigational New Drugs. 2009;27:246–252.

Kavitha K, Vidya Priyadarsini R, Anitha P, Ramalingam K, Sakthivel R, Purushotha-man G, Singh AK, Karunagaran D, Nagini S. Nimbolide, a neem limonoid abrogates canonical NF-kappaB and Wnt signaling to induce caspase-dependent apoptosis in human hepatocarcinoma (HepG2) cells. European Journal of Pharmacology. 2012; 681:6–14.

Hsu S, Lewis J, Singh B, Schoenlein P, Osaki T, Athar M, et al. Green tea polyphenol targets the mitochondrial in tumor cells inducing caspase 3-dependent apoptosis. Anticancer Res. 2003;23: 1533—9.

Hsu S, Yu FS, Lewis J, Singh B, Borke J, Osaki T, et al. Induction of p57 is required for cell survival when exposed to green tea polyphenols. Anticancer Res 2002;22: 4115—20.

Sophia J, Kiran Kishore TK, Kowshik J, Mishra R, Nagini S. Nimbolide, a neem limonoid inhibits phosphatidyl inositol-3 kinase to activate glycogen synthase kinase-3β in a hamster model of oral oncogenesis. Sci. Rep. 2016;6:22192.

Subramani R, et al. Nimbolide inhibits pancreatic cancer growth and metastasis through ROS-mediated apoptosis and inhibition of epithelial-tomesenchymal transition. Sci. Rep. 2016;6:19819.

Theaflavin Effectiveness, Safety, and Drug Interaction on RxList. rxlist.com.

Retrieved 24 April 2018.

Schuck AG, Ausubel MB, Zuckerbraun HL, Babich H. Theaflavin-3-digallate, a component of black tea: an inducer of oxidative stress and apoptosis. Toxicol in vitro. 2008;22:598—609.

Hsu S, Lewis J, Singh B, Schoenlein P, Osaki T, Athar M, et al. Green tea polyphenol targets the mitochondrial in tumor cells inducing caspase 3-dependent apoptosis. Anticancer Res. 2003;23:1533-9.

Seong-Eon Kim, Sang-Hun Shin, Jae-Yeol Lee, Chul-Hoon Kim, In-Kyo Chung, Hae-Mi Kang, Hae-Ryoun Park, Bong-Soo Park & In-Ryoung Kim; nutrition and cancer 2018;70(1):125–135.

Wang Y, Catana F, Yang Y, Roderick R, and Van Breemen RB: An LC-MS method for analyzing total resveratrol in grape juice, cranberry juice, and in wine. J Agric Food Chem. 2002;50:431–435.

Ang M, Cai L, Udeani GO, Slowing KV, Thomas CF, et al. Cancer chemopreven-tive activity of resveratrol, a natural product derived from grapes. Sci. 1997;275:218–220.

Bhardwaj A, Sethi G, Vadhan-Raj S, Bueso-Ramos C, Takada Y, et al. Resveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresis-tance through downregulation of STAT3 and nuclear factor-kB–regulated antia-poptotic and cell survival gene products in human multiple myeloma cells. Blood. 2007;109:2293–2302.

Seong-Eon Kima, Sang-Hun Shina, Jae-Yeol Leea, Chul-Hoon Kimb, In-Kyo Chunga, Hae-Mi Kangc E, Hae-Ryoun Parkd E, Bong-Soo Parkc E and In-Ryoung Kim. Nutrition and Cancer. 2018;70(1):125–135.

Zhou H-B, Yan Y, Sun Y-N, and Zhu J-R: Resveratrol induces apoptosis in human esophageal carcinoma cells. World J Gastroenterol. 2003;9:408–411.

Youle RJ, and Strasser A: The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol. 2008;9:47–59.

Xiao-Dong Yu, Jing-lei Yang, Wan-Lin Zhang, Dong-Xu Liu. Tumor Biol; 2015.

Bai Y, Mao QQ, Qin J, Zheng XY, Wang YB, Yang K, Shen HF, Xie LP. Resveratrol induces apoptosis and cell cycle arrest of human T24 bladder cancer cells in vitro and inhibits tumor growth in vivo. Cancer Sci. 2010;101:488–493.

Aziz MH, Nihal M, Fu VX, Jarrard DF, Ahmad N. Resveratrol-caused apoptosis of human prostate carcinoma LNCaP cells is mediated via modulation of phosphatidy-linositol 30 -kinase/Akt pathway and Bcl-2 family proteins. Mol. Cancer Ther. 2006;5: 1335–1341.

Faber AC, Dufort FJ, Blair D, Wagner D, Roberts MF, Chiles TC. Inhibition of phosphatidylinositol 3-kinase-mediated glucose metabolism coincides with resveratrol-induced cell cycle arrest in human diffuse large B-cell lymphomas. Biochem. Pharmacol. 2006;72:1246–1256.

He X, Wang Y, Zhu J, Orloff M, Eng C. Resveratrol enhances the anti-tumor activity of the mTOR inhibitor rapamycin in multiple breast cancer cell lines mainly by suppressing rapamycin-induced AKT signaling. Cancer Lett. 2011;301:168– 176.

Banerjee Mustafi S, Chakraborty PK, Raha S. Modulation of Akt and ERK1/2 pathways by resveratrol in chronic myelogenous leukemia (CML) cells results in the downregulation of Hsp70. PLoS ONE. 2010;5:e8719.

Parekh P, Motiwale L, Naik N, Rao KV. Downregulation of cyclin D1 is associated with decreased levels of p38 MAP kinases, Akt/PKB and Pak1 during chemopreven-tive effects of resveratrol in liver cancer cells. Exp. Toxicol. Pathol. 2011;63:167–173.

Colin D, Limagne E, Jeanningros S, Jacquel A, Lizard G, Athias A, Gambert P, Hichami A, Latruffe N, Solary E, et al. Endocytosis of resveratrol via lipid rafts and activation of downstream signaling pathways in cancer cells. Cancer Prev. Res. 2011;4:1095–1106.

Pozo-Guisado E, Merino JM, Mulero-Navarro S, Lorenzo-Benayas MJ, Centeno F, Alvarez-Barrientos A, Fernandez-Salguero PM. Resveratrol-induced apoptosis in MCF-7 human breast cancer cells involves a caspase-independent mechanism with downregulation of Bcl-2 and NF-κB. Int. J. Cancer. 2005;115:74–84.

Benitez DA, Hermoso MA, Pozo-Guisado E, Fernandez-Salguero PM, Castellon EA. Regulation of cell survival by resveratrol involves inhibition of NF κB-regulated gene expression in prostate cancer cells. Prostate. 2009;69:1045–1054.

Cecchinato V, Chiaramonte R, Nizzardo M, Cristofaro B, Basile A, Sherbet GV, Comi P. Resveratrol-induced apoptosis in human T-cell acute lymphoblastic leukaemia MOLT-4 cells. Biochem. Pharmacol. 2007; 74:1568–1574.

Kueck A, Opipari AW Jr., Griffith KA, Tan L, Choi M, Huang J, Wahl H, Liu JR. Resveratrol inhibits glucose metabolism in human ovarian cancer cells. Gynecol. Oncol. 2007;107:450–457.

Li Y, Liu J, Liu X, Xing K, Wang Y, Li, F, Yao L. Resveratrol-induced cell inhibition of growth and apoptosis in MCF7 human breast cancer cells are associated with modulation of phosphorylated Akt and caspase-9. Appl. Biochem. Biotechnol. 2006;135:181–192.

Sexton E, Van Themsche C, LeBlanc K, Parent S, Lemoine P, Asselin E. Resveratrol interferes with AKT activity and triggers apoptosis in human uterine cancer cells. Mol. Cancer. 2006;5:45.

Bhardwaj A, Sethi G, Vadhan-Raj S, Bueso-Ramos C, Takada Y, Gaur U, Nair AS, Shishodia S, Aggarwal BB. Resveratrol inhibits proliferation, induces apoptosis and overcomes chemoresis-tance through down-regulation of STAT3 and nuclear factor-κB-regulated antia-poptotic and cell survival gene products in human multiple myeloma cells. Blood. 2007;109:2293–2302.

Jazirehi AR, Bonavida B. Resveratrol modifies the expression of apoptotic regulatory proteins and sensitizes non-Hodgkin’s lymphoma and multiple myeloma cell lines to paclitaxel-induced apoptosis. Mol. Cancer Ther. 2004;3, 71–84.

Ji Young Kim, Tae Jin Cho , Bok Hee Woo, Kyung Un Choi, Chang Hun Lee, Mi Heon Ryu , Hae Ryoun Park ; archives of oral biology. 2012;57:1018 – 1025.

Sharma RA, Gescher AJ, Steward WP, Curcumin: the story so far. Eur J Cancer. 2005;41: 1955 – 1968.

Surh YJ. Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer . 2003;3:768 – 780.

Karunagaran D, Rashmi R, Kumar TR. Induction of apoptosis by curcumin and its implications for cancer therapy. Curr Cancer Drug Targets. 2005;5:117– 129.

Salvioli S, Sikora E, Cooper EL, Franceschi C. Curcumin in cell death processes: a challenge for CAM of age-related pathologies. Evid Based Complement Alternat Med. 2007;4:181– 190.

Holy JM. Curcumin disrupts mitotic spindle structure and induces micronucleation in MCF-7 breast cancer cells. Mutat Res. 2002;518:71–84.

Aoki H, Takada Y, Kondo S, Sawaya R, Aggarwal BB, Kondo Y. Evidence that curcumin suppresses the growth of malignant gliomas in vitro and in vivo through induction of autophagy: Role of Akt and extracellular signal-regulated kinase signaling pathways. Mol Pharmacol. 2007; 72:29–39.

Degterev A, Yuan J. Expansion and evolution of cell death programmes. Nat Rev Mol Cell Biol. 2008;9:378–390.

O’Sullivan-Coyne G, O’Sullivan GC, O’Donovan TR, Piwocka K, McKenna SL. British Journal of Cancer. 2009;101:1585 – 1595.

Li N, Chen X, Han C, Chen J. Chemopreventive effect of tea and curcumin on DMBA-induced oral carcinogenesis in hamsters. Wei Sheng Yan Jiu. 2002;31:354—357.

Bielak-Zmijewska A, Koronkiewicz M, Skierski J, Piwocka K, Radziszewska E, Sikora E. Effect of curcumin on the apoptosis of rodent and human nonproliferating and proliferating lymphoid cells. Nutr. Cancer. 2000;38:131-138.

Franken NA, Rodermond HM, Stap J, et al. Cologenic assay of cells in vitro.Nat Protoc. 2006;2315-9.

Keshava Rohini1, Muniyappa Nagesh 2, Gope Rajalakshmi3 Saligrama Ramaswamaiah Ananthanarayana1. Asian Pac J Cancer Prev. 2016;17(4):1891-1898.

Yoon Heein, Park Junhee, Park Kwang-Kyun, Kim Jim, Bandara N. Champika, Bandara BMR, Tilakaratne M, Wanninayake 6, Won-Yoon Chung. Evidence-based complementary and alternative medicine. 2017;8.